1
Clinical Trials associated with HOPO 14-1An Open-Label, First-In-Human Study of Single Oral Doses of HOPO 14-1 Evaluating Safety, Tolerability, Pharmacokinetics, and Excretion in Healthy Participants
The study objectives are to define the safety and tolerability profile of oral, single ascending dose (SAD) levels of HOPO 14-1 capsules in cohorts of healthy participants and to assess the pharmacokinetic (PK) and excretion profile of HOPO 14-1. The study hypothesis is that a single dose of HOPO 14-1 will be safe and tolerable up to 7500 mg.
100 Clinical Results associated with HOPO 14-1
100 Translational Medicine associated with HOPO 14-1
100 Patents (Medical) associated with HOPO 14-1
100 Deals associated with HOPO 14-1